Clinical trial Recruiting at 1 site Observational Ages 18 and up

Hip arthroplasty with a short cementless stem using a direct anterior approach

Official title: Clinical and Radiographic Evaluation of a Short Stem for Primary Hip Replacement Performed by Anterior Approach: A Retrospective and Prospective Study

Run by Istituto Ortopedico Rizzoli · NCT07600632 · Data updated 2026-11-12

This study tests whether a short, cementless hip stem implanted through a minimally invasive direct anterior approach works well in adults with hip arthritis.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedSeptember 12, 2025
Main results expectedSeptember 2027
Study endsDecember 2030
Registry record updatedMay 20, 2026
Trial IDNCT07600632 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with primary hip osteoarthritis or osteonecrosis undergoing primary total hip arthroplasty with a minimally invasive direct anterior approach and a cementless short stem.

Probably not a fit

Patients who have secondary hip arthritis, non-anterior approaches, cemented components, or inadequate documentation may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data on patients undergoing primary total hip arthroplasty with a cementless, hydroxyapatite-coated short stem via a direct anterior approach. It will evaluate clinical outcomes, radiographs, and perioperative factors over at least two years of follow-up. The goal is to understand survivorship, radiographic features, and functional results in this younger, more active population. The analysis will help clarify whether the approach and stem design provide favorable outcomes compared with historical experiences. Methods include retrospective and prospective data collection from a single center in Bologna, Italy.

Why it matters

Potential benefit: If successful, the approach could offer a bone-preserving option with potentially easier implantation and favorable function for younger patients.

How similar studies have gone: Prior reports on similar short stems and anterior approaches show mixed results for survivorship and radiographic changes, making this observational data important.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of primary hip osteoarthritis or osteonecrosis
* Minimally invasive direct anterior approach
* Cementless femoral component
* Minimum follow-up of 2 years
* Patient willingness to participate in the study with written informed consent
* Age over 18 years
* Male or female patients

Exclusion Criteria:

* Other diagnoses of secondary hip osteoarthritis
* Non-anterior surgical approach
* Cemented or other types of components
* Patient unwillingness to participate in the study
* Inadequate clinical and radiological documentation

Where it's running

  • IRCCS Istituto Ortopedico Rizzoli
    Bologna, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.